SNDX

MODERATE

Syndax Pharmaceuticals Inc

CIK: 0001395937

Strong Sell (50% confidence)

Last activity: Feb 9, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $172.35M

Net Income -$285.42M

Total Cash $394.07M

Current Ratio 5.02

Insider	Buys	Sells	Net Value	Holdings
Metzger Michael A Chief Executive Officer	0	2	-$514K	491,690 shares $10.34M
Goldan Keith A. Chief Financial Officer	0	2	-$115K	140,429 shares $2.95M

SELL Metzger Michael A (Chief Executive Officer)

17,159 shares @ $21.03

$361K

Feb 9, 2026

Conviction: | View SEC Filing →

SELL Goldan Keith A. (Chief Financial Officer)

3,410 shares @ $21.03

$72K

Feb 9, 2026

Conviction: | View SEC Filing →

SELL Metzger Michael A (Chief Executive Officer)

7,412 shares @ $20.62

$153K

Feb 6, 2026

Conviction: | View SEC Filing →

SELL Goldan Keith A. (Chief Financial Officer)

2,082 shares @ $20.62

$43K

Feb 6, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.